What is NEU's health score?

NEWMARKET CORP (NEU) has a TradeApes health score of 61 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NEU's estimated fair value?

Based on our 5-year discounted cash flow model, NEWMARKET CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is NEU undervalued or overvalued?

Our model currently rates NEU as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

To Unlock Full Report

1 free score card remaining

NEWMARKET CORP (NEU)

Materials Inconclusive inconclusive healthy

$761.91

Updated: 2026-07-16

TradeApes Score

Financial Strength

75 Strong

Operating Trend

55 Mixed

Relative Value

55 Mixed

Capital Allocation

50 Mixed

Risk Management

70 Healthy

Key Findings

+ Strong interest coverage — EBIT covers interest 10×+

Unlock Full Report →

− Altman Z-Score in grey zone — uncertain financial stability

Unlock Full Report →

Industry Related Stocks

Alto Ingredients, Inc. (ALTO) AEMETIS, INC (AMTX) BRASKEM SA (BAK) BLUE BIOFUELS, INC. (BIOF) Bolt Projects Holdings, Inc. (BSLK) Bolt Projects Holdings, Inc. (BSLKW)

See all Materials stocks →

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.